Back to Search
Start Over
Regulation of Anion Channel LRRC8 Volume-Regulated Anion Channels in Transport of 2'3'-Cyclic GMP-AMP and Cisplatin under Steady State and Inflammation
- Source :
- Journal of immunology (Baltimore, Md. : 1950). 206(9)
- Publication Year :
- 2020
-
Abstract
- The recently identified anion channel LRRC8 volume-regulated anion channels (VRACs) are heteromeric hexamers constituted with the obligate LRRC8A subunit paired with at least one of the accessory LRRC8B to LRRC8E subunits. In addition to transport chloride, taurine, and glutamate, LRRC8 VRACs also transport the anticancer agent cisplatin and STING agonists 2′3′-cyclic GMP–AMP (cGAMP) and cyclic dinucleotides; hence, they are implicated in a variety of physiological and pathological processes, such as cell swelling, stroke, cancer, and viral infection. Although the subunit composition largely determines VRAC substrate specificity, the opening of various VRAC pores under physiological and pathological settings remains enigmatic. In this study, we demonstrated that VRACs comprising LRRC8A and LRRC8E (LRRC8A/E–containing VRACs), specialized in cGAMP transport, can be opened by a protein component present in serum under resting condition. Serum depletion ablated the tonic activity of LRRC8A/E–containing VRACs, decreasing cGAMP transport in various human and murine cells. Also, heating or proteinase K treatment abolished the ability of serum to activate VRAC. Genetic analyses revealed a crucial role for cGAMP synthase (cGAS) in serum/TNF–promoted VRAC activation. Notably, the presence of cGAS on the plasma membrane, rather than its DNA-binding or enzymatic activity, enabled VRAC activation. Moreover, phospholipid PIP2 seemed to be instrumental in the membrane localization of cGAS and its association with VRACs. Corroborating a role for LRRC8A/D–containing VRACs in cisplatin transport, serum and TNF markedly potentiated cisplatin uptake and killing of cancer cells derived from human or mouse. Together, these observations provide new insights into the complex regulation of VRAC activation and suggest a novel approach to enhance the efficacy of cGAMP and cisplatin in treating infection and cancer.
- Subjects :
- Taurine
Protein subunit
Immunology
Inflammation
Antineoplastic Agents
Mice, Transgenic
03 medical and health sciences
chemistry.chemical_compound
Mice
0302 clinical medicine
medicine
Immunology and Allergy
Animals
Cisplatin
chemistry.chemical_classification
Glutamate receptor
Membrane Proteins
Cell biology
Mice, Inbred C57BL
Enzyme
chemistry
Cancer cell
Tumor necrosis factor alpha
medicine.symptom
Nucleotides, Cyclic
030215 immunology
medicine.drug
Subjects
Details
- ISSN :
- 15506606
- Volume :
- 206
- Issue :
- 9
- Database :
- OpenAIRE
- Journal :
- Journal of immunology (Baltimore, Md. : 1950)
- Accession number :
- edsair.doi.dedup.....c000c1f3e9440562677d96fef0f16bb7